Lamivudine ViiV: Opinion on medicine for use outside EU


Opinion on medicine for use outside the European Union
Withdrawn opinion


The opinion for Lamivudine ViiV for use outside the European Union has been withdrawn at the request of the opinion holder.

Opinion details

Product details
Name of medicinal product
Lamivudine ViiV
Agency opinion number
Opinion status
Withdrawn opinion
Active substance
International non-proprietary name (INN) or common name
Therapeutic area (MeSH)
HIV Infections
Anatomical therapeutic chemical (ATC) code
Publication details
Opinion holder

ViiV Healtcare UK Limited
Greenford Road
Greenford, Middlesex UB6 0NN
United Kingdom

Date of opinion

Product information

17/09/2015 Lamivudine ViiV H-W-673-WS-755


Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Antivirals for systemic use

Therapeutic indication

Lamivudine is indicated as part of antiretroviral combination therapy for the treatment of human immunodeficiency virus (HIV) infected adults and children.

Assessment history

How useful was this page?

Add your rating